NYSE:GMEDMedical Equipment
Why Globus Medical (GMED) Is Up 8.2% After Raising 2026 Revenue Guidance And Integration Outlook
Globus Medical, Inc. recently reported preliminary unaudited results showing fourth-quarter 2025 sales of about US$823.2 million and full-year 2025 sales of roughly US$2.94 billion, while setting 2026 revenue guidance between US$3.18 billion and US$3.22 billion.
Management highlighted strong contributions from U.S. Spine and Enabling Technologies plus ongoing integration of the NuVasive and Nevro acquisitions as key supports for its higher-than-expected 2026 revenue and earnings...